Evaluation of the safety and efficacy of skin penetration enhancer Putocrin®

Zongxiao Cen,Zhiyuan Chen,Ding Wang,Xueping Chen,Junyuan Chen
DOI: https://doi.org/10.1111/jocd.16409
2024-06-13
Journal of Cosmetic Dermatology
Abstract:Background Substances that can efficiently enhance skin penetration while exerting no adverse effect are useful for drug and cosmetics formulation. Objective To investigate the safety and enhance skin penetration efficacy of Putocrin®, a combination containing 2% isosorbide dimethyl ether, 1% pentanediol, and 0.5% inositol. Methods An in vitro keratinocyte cell assay using 3‐(4,5‐dimethylthiazolyl‐2)‐2,5 diphenyltetrazolium bromide (MTT), and an in vitro EpiKutis® skin study adopted hematoxylin and eosin staining, immunostaining, and liquid chromatography–mass spectrometry (LC–MS) analysis were carried out to investigate the safety of Putocrin®. A pigskin‐Franz cell system experiment applied high‐performance liquid chromatography (HPLC) to compare the skin penetration efficiency of fluorescein isothiocyanate (Fitc)‐labeled tranexamic acid with or without the assistance of Putocrin®. The safety and efficacy of Putocrin® was further evaluated on zebrafish embryos. Results The MTT assay showed that Putocrin® at concentration ≤2.5% did not significantly affect cell viability. The in vitro EpiKutis® skin study revealed that 2.5% Putocrin® did not affect skin morphology, filaggrin content, ceramide/protein, or fatty acid/protein ratios, but significantly increased loricrin content by 86.00% (p
dermatology
What problem does this paper attempt to address?